Clinical Trial Update: Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848 [Phase 2]

View source ↗

Summary

Phase 2 efficacy trial update for intranasal AZD8848 in allergic rhinitis. The study is completed and results were posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• AZD8848

Snippet

Sponsor: AstraZeneca | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2016-01-07